World’s leading joint care product Cosequin launched in India


Vivaldis announces its collaboration with Bioiberica, a Spanish biotech company, which is specialised in research, development, production and commercialisation of ‘biomolecules’. Bioiberica is present in more than 65 countries. With its collaboration with Bioiberica, Vivaldis stands committed to its dictum to contribute to the prosperity of pet healthcare industry by introducing pioneering and path breaking product in India.  Bioiberica has consolidated its leadership in production of Glycosaminoglycans including Chondroitin sulphate, Hyaluronic acid & Glucosamine. Under the collaboration, Cosequin, a world’s leading joint care product, has been launched in India during the Orthopedic Workshop held recently at Shirval in Maharashtra. Conducted by Dr Milind Hatekar from Veterinary Orthopedic Foundation, the workshop witnessed a host of well known veterinarians including Dr Bruno Peirone, Dr Matthias Frank, Dr Daniel Damur and Dr Luca Redaelli from Europe, who unveiled the newly launched Cosequin during the event. Kunal Khanna, founder and CEO of Vivaldis and Sergio Garcia from Bioiberica discussed about Cosequin and the association with Bioiberica during the event. Vivaldis has plans to introduce three more new products from Bioiberica in the Indian market by May this year. The new range will include a product for atopic dermatitis and two products for digestive health. This alliance between Vivaldis and Bioiberica will proffer a range of revolutionary products that add value to the pets’ health and improve their quality of life.